Item 2.02. Results of Operations and Financial Condition.
On March 31, 2009, we issued a press release announcing, among other things, our financial results for the quarter and year ended December 31, 2008. A copy of this press release is attached as Exhibit 99.1 to this Current Report. In addition, our Form 10-K filed with the Securities and Exchange Commission on March 31, 2009, will include an audit opinion containing a going concern qualification.
The information in this Item 2.02 and Item 9.01, and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits

99.1 Press release of IDM Pharma, Inc. dated March 31, 2009.

---

Table of Contents